Biosynthesis of Cannabinoids and Psychedelics. Unleashed.
Our mission is to enhance synthetic biology of cannabinoids and psychedelics by enabling, unblocking bottlenecks, and boosting-up their natural production processes implementing our disruptive set of discoveries of novel genes, genetic pathways, and molecules, and their applications.
Enhancing Cannabinoid and Psychedelic Active Ingredients for Innovative Therapeutics and CPG
We strive to make a large array of natural lab made cannabinoids, including minor and modified cannabinoids, and a list of the most sought after psychoactive active ingredients, more accessible for the production of innovative Active Pharma Ingredients (APIs) and Active Ingredients(AIs) for high end Consumer Packaged Goods (CPG).
Our focus is to enhance and unleash the power of the very base of the biosynthetic based multi billion industry value chain pyramid, help manufacture great products and offer progressive solutions for the health and wellbeing of millions of people around the world.
News & Articles
News & Articles
About us
Founded in 2019 and lead by a team of experienced entrepreneurs, Xinteza began operations in 2020 with its strategic partners that include The Weizmann Institute of Science, with an extensive ultra-innovative research lead by Prof. Asaph Aharoni, and industry players as its partners andinvestors, such as IM Cannabis (NASDAQ: IMCC, CSE: IMCC), to name one.
Xinteza is engaged in the research and discovery of a wide array of new genes and ultranovel genetic paths for the biosynthesis of cannabinoids and psychoactive ingredients, and the development of their bio-production methods. Xinteza holds the exclusive license for both cannabinoids and psychoactives from the Weizmann Institute and is building an unprecedented portfolio of dozens of related IP and patents.
.svg)
Head of Weizmann Institute’s Plant Metabolomics lab and head of Plant and Environmental Sciences department. Published more than 180 research papers and 30 book chapters, 30 patent applications and 5 start-ups based on his research. Recipient of notable awards and a review editor for the Plant Journal. PhD/Postdoc, Wageningen University; MSC, Hebrew University
Seasoned executive with over 25 years of experience as CEO (5 times), senior executive management and investment positions, and as an entrepreneur – in hi-tech, Internet and data systems, media/press and marketing. IMBA, Northwestern University and Tel Aviv University; BA Cinema & TV, Tel Aviv University
Prof. Asaph Aharoni
Prof. Asaph Aharoni | Scientific Co-Founder
Alon Gal
Alon Gal | Co-Founder, CEO
Dr. Zohar Koren
Dr. Zohar Koren | Co-Founder, CTO
Ron Klein
Ron Klein | COO & CFO
People & Partners
Seasoned executive with over 25 years of experience as CEO (5 times), senior executive management and investment positions, and as an entrepreneur – in hi-tech, Internet and data systems, media/press and marketing. IMBA, Northwestern University and Tel Aviv University; BA Cinema & TV, Tel Aviv University
Seasoned executive with 20 years of experience
in general management, BD, global M&As/JVs,
and finance. Formerly CEO of ChickP, Source of
Sounds, Silynx.
IMBA, Northwestern University and Tel Aviv
University; BA Accounting and Economics, Tel Aviv
university systems, IMBA, Northwestern
University and Tel Aviv University; BA Cinema &
TV, Tel Aviv University
Founder and CEO, SciCann Therapeutics Inc; Founder
and CEO, Cannabics Pharmaceuticals Inc. (OTCQB:
CNBX); VP BD, Mor Research Applications Ltd. (Clalit
Healthcare tech transfer unit). Veteran of Talpiot
Program (IDF's elite of officers pre-trained as its
spearhead tech leaders). Ph.D. and M.Sc. in Protein
Science and Computational Biology, University of
Haifa; B.Sc. Mathematics, Physics and Biology, The
Hebrew University of Jerusalem
.svg)
Head of Weizmann Institute’s Plant Metabolomics lab and head of Plant and Environmental Sciences department. Published more than 180 research papers and 30 book chapters, 30 patent applications and 5 start-ups based on his research. Recipient of notable awards and a review editor for the Plant Journal. PhD/Postdoc, Wageningen University; MSC, Hebrew University
.png)
